Migneco G, Mascarella A, Tripi S, La Cascia C, Cusimano R, Vigneri S, Attianese R, Scialabba A
Istituto di Clinica Medica I, Università di Palermo.
Boll Ist Sieroter Milan. 1987;66(3):181-4.
Anti-HBc prevalence in alcoholics, chronic hepatotoxic drugs users, exposed to both these factors, and not exposed to alcohol and drugs cirrhotic patients was compared. Anti-HBc prevalence was significantly higher both in alcoholics and in hepatotoxic drugs users cirrhotic patients, and no statistically significant difference was found between the prevalence of anti-HBc in these two groups. In male cirrhotic patients the risk of HBV infection was 4.4 times higher in chronic hepatotoxic drugs users, 4.7 times higher in alcoholics, and 6.9 times higher in patients exposed both to alcohol and drugs. These results support the hypothesis that also chronic consumption of hepatotoxic drugs may be associated with a greater prevalence of HBV infection.
比较了酗酒者、长期使用肝毒性药物者、同时接触这两种因素者以及未接触酒精和药物的肝硬化患者中抗-HBc的流行情况。抗-HBc在酗酒的肝硬化患者和使用肝毒性药物的肝硬化患者中的流行率均显著更高,且这两组中抗-HBc的流行率之间未发现统计学上的显著差异。在男性肝硬化患者中,长期使用肝毒性药物者感染HBV的风险高4.4倍,酗酒者高4.7倍,同时接触酒精和药物者高6.9倍。这些结果支持这样的假设,即长期使用肝毒性药物也可能与HBV感染的更高流行率相关。